Consistent with the findings of Fackler et al., methylation differences in the promoters of the RASSF1A, Cyclin D2, RAR-beta, and Hin-1 genes were detected between lobular carcinoma in situ and invasive lobular carcinoma of the breast (4). Here, RARB is linked to breast carcinoma.